ALK-Abelló A/S
ALK-B
Clasificación en acciones
#2325
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
Precio por acción
$38.39
Capitalización bursátil
$8.52B
Cambio (1 día)
1.68%
Cambio (1 año)
16.26%
País
DK
Comercio ALK-Abelló A/S (ALK-B)
Categoría
Healthcare
Número de acciones en circulación de ALK-Abelló A/S (ALK-B)
Número de acciones en circulación al June 2026: 221.88M
Según los últimos informes financieros y el precio de las acciones de ALK-Abelló A/S, el número actual de acciones en circulación es 221.88M. Al final de December 2023, la empresa tenía 221.15M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de ALK-Abelló A/S (ALK-B) desde 2004 hasta 2026
Acciones en circulación al final de cada año
| Año | Acciones en circulación | Cambiar |
|---|---|---|
| 2026 (TTM) | 221.88M | 0.25% |
| 2024 | 221.32M | 0.08% |
| 2023 | 221.15M | 0.29% |
| 2022 | 220.50M | 0.51% |
| 2021 | 219.39M | 0.49% |
| 2020 | 218.32M | 0.14% |
| 2019 | 218.01M | 0.31% |
| 2018 | 217.33M | 9.53% |
| 2017 | 198.43M | 1.07% |
| 2016 | 196.33M | 1.15% |
| 2015 | 194.09M | 0.46% |
| 2014 | 193.20M | 0.00% |
| 2013 | 193.20M | -0.87% |
| 2012 | 194.91M | -1.53% |
| 2011 | 197.94M | -0.14% |
| 2010 | 198.22M | -0.49% |
| 2009 | 199.19M | -0.34% |
| 2008 | 199.88M | -0.33% |
| 2007 | 200.53M | -0.74% |
| 2006 | 202.02M | 0.47% |
| 2005 | 201.07M | -0.60% |
| 2004 | 202.28M | 0.00% |
Acciones en circulación de empresas similares o competidores
| Empresa | Acciones en circulación | Diferencia | País |
|---|---|---|---|
| 253.90M | 14.43% |
US
|
|
| 396.00M | 78.48% |
US
|
|
| 478.91M | 115.84% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -71.97% |
NL
|
